The FMBA has developed a vaccine against monkey pox


As Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA) of Russia, said in her speech at the Far Eastern Economic Forum, FMBA scientists have developed a vaccine against monkey pox and an allergy drug. TASS reports.

During the preclinical trials, the vaccine showed high immunogenicity and safety. According to Skvortsova, unlike the smallpox vaccine, it does not cause serious side effects.

Moreover, the Institute of Immunology of the FMBA has developed a vaccine to prevent allergy. It is currently at the stage of clinical trials, and the results have been positive.

“This is a whole line of drugs… The vaccine against allergy is already undergoing clinical trials in respect of different types of pollinosis, and it has been demonstrating good results so far,” Interfax quotes Veronika Skvortsova as saying.

As it became known earlier, the FMBA has developed two new drugs for leprosy and malaria.